Scripps Laboratories

Executive Summary

Scripps Laboratories is a privately-held biotechnology company founded in 1976 and headquartered in San Diego, California. It specializes in manufacturing and supplying high-quality proteins, antibodies, and assay reagents for the in vitro diagnostics (IVD) and life science research markets. The company's product portfolio spans key therapeutic areas including cardiology, oncology, reproductive health, and inflammation. With over four decades of industry experience, Scripps Laboratories has established itself as a reliable partner for diagnostic manufacturers and research institutions, leveraging its expertise in reagent development and large-scale production. As a private entity, the company does not disclose financials, but its long-standing presence and diversified product line suggest stable operations and a loyal customer base. The company remains focused on maintaining product quality and expanding its catalog to meet evolving market demands, though growth is likely incremental rather than disruptive due to the mature nature of its core markets.

Upcoming Catalysts (preview)

• Q2 2027Expansion of antibody catalog into new therapeutic areas80% success
• 2026New strategic collaboration with major IVD firms70% success
• H2 2026Upgrade of manufacturing facility to increase capacity90% success